Your browser doesn't support javascript.
loading
Efficacy of Covexir® (Ferula foetida oleo-gum) treatment in symptomatic improvement of patients with mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial.
Hasanpour, Maede; Safari, Hossein; Mohammadpour, Amir Hooshang; Iranshahy, Milad; Dehghan Nayyeri, Mohammad Javad; Farhadi, Faegheh; Emami, Bahareh; Iranshahi, Mehrdad.
Afiliação
  • Hasanpour M; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Safari H; Hasheminezhad Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mohammadpour AH; Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Iranshahy M; Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Dehghan Nayyeri MJ; Hasheminezhad Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Farhadi F; Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Emami B; Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Iranshahi M; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Phytother Res ; 36(12): 4504-4515, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35896167

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ferula / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Phytother Res Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ferula / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Phytother Res Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã